Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/11496
Title: Prokinetics-Safety and Efficacy: the European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society Expert Review
Authors: Bor, Serhat
Kalkan, İsmail H.
Savarino, Edoardo
Rao, Satish
Tack, Jan
Pasricha, Jay
Cangemi, David
Keywords: efficacy
gastrointestinal motility
prokinetics
safety
Irritable-Bowel-Syndrome
Placebo-Controlled Trial
Severe Chronic Constipation
Randomized Clinical-Trial
Receptor Partial Agonist
Gastrointestinal Contractile Activity
Chronic Intestinal Pseudoobstruction
Acute Colonic Pseudoobstruction
Mitemcinal Fumarate Gm-611
Esophageal Acid Exposure
Publisher: Wiley
Abstract: BackgroundProkinetics are a class of pharmacological drugs designed to improve gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its merits and drawbacks, and based on current evidence as high-quality studies are limited, we have no clear recommendation on one class or other. However, there remains a large unmet need for both regionally selective and/or globally acting prokinetic drugs that work primarily intraluminally and are safe and without systemic side effects.PurposeHere, we describe the strengths and weaknesses of six classes of prokinetic drugs, including their pharmacokinetic properties, efficacy, safety and tolerability and potential indications.
URI: https://doi.org/10.1111/nmo.14774
https://hdl.handle.net/20.500.11851/11496
ISSN: 1350-1925
1365-2982
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

Page view(s)

160
checked on Dec 16, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.